Drugs / Caprylic Triglyceride Oil
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02833012 | Jul → Sep 2016 | — | Cerecin | Completed | No outcome recorded |
| Phase 1 | NCT02747602 | Apr → May 2016 | — | Cerecin | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | caprylic triglyceride oil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02747602 ↗ |
| Known as | CT oil | “To compare serum ketone body (i.e., total ketones, β hydroxybutyrate, and estimate of acetoacetate) levels after single dose administration of caprylic triglyceride (CT) oil,...” NCT02833012 ↗ |